| Serial Number | 86364754 |
| Word Mark | SOCTEC |
| Filing Date | Tuesday, August 12, 2014 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 19, 2018 |
| Registration Number | 5494819 |
| Registration Date | Tuesday, June 19, 2018 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 3, 2018 |
| Goods and Services | Pharmaceuticals having a self-orienting effect, namely, orally delivered pharmaceuticals with modified time release into the gastrointestinal system; gastro retentive pharmaceuticals; self orienting pharmaceuticals in the form of capsules, namely, capsules consisting of segments of varied functions and absorption rates, resulting in controlled release into the gastrointestinal tract; Gastrointestinal drug delivery preparations for medical, surgical and biological purposes; chronotherapy-focused tablets, analgesics; Medicines for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; medicinal preparations for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; capsules for the release of colonic drug delivery; pharmaceuticals for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders, medical and veterinary preparations for body slimming purposes; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pre-filled vials containing medical diagnostic reagents; exclude goods being related to the treatment of respiratory diseases |
| Translation of Words in Mark | The word(s) "SOCTEC" has no meaning in a foreign language. |
| Goods and Services | Medical services; veterinary services; hygienic care for human beings or animals; medical analysis for the diagnosis and treatment of persons treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmacy advice; provision of information relating to medical, surgical and veterinary matters online from a computer database or over the Internet; exclude services in the field of inhalation technology |
| Goods and Services | inhalers for medical purposes; injection apparatus, instruments and devices, namely, medical apparatus in the nature of an infusion injection device for administering drugs; apparatus, instruments and devices, namely, automated drug delivery systems for storing and dispensing medical, surgical and veterinary preparations, capsules, powders, tablets and pills; instruments and apparatus for the administration of self-orientation therapy and prophylaxis preparations and substances, namely, gastrointestinal drug delivery systems, syringes and fluid injectors for medical purposes; exclude goods being related to the treatment of respiratory diseases |
| Goods and Services | Scientific and technological services, namely, custom design exclusively in the pharmaceuticals and medical fields; design services exclusively in the pharmaceuticals and medical fields; drug development and custom design of pharmaceuticals and medical goods; exclude services in the field of inhalation technology |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 21, 2014 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 21, 2014 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 21, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 21, 2014 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Jagotec AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | 4132 Muttenz CH |
| Party Name | Jagotec AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 4132 Muttenz CH |
| Party Name | Jagotec AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 4132 Muttenz CH |
| Event Date | Event Description |
| Monday, June 19, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, June 19, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Sunday, April 29, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 3, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 3, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 14, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, February 26, 2018 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, February 13, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 13, 2018 | EXAMINER'S AMENDMENT ENTERED |
| Monday, February 12, 2018 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, February 12, 2018 | EXAMINERS AMENDMENT E-MAILED |
| Monday, February 12, 2018 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, November 27, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 27, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, November 27, 2017 | NON-FINAL ACTION WRITTEN |
| Friday, November 3, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 3, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 2, 2017 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, October 31, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, October 31, 2017 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, October 31, 2017 | SUSPENSION LETTER WRITTEN |
| Tuesday, October 31, 2017 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, October 31, 2017 | CASE RETURNED TO EXAMINATION |
| Tuesday, October 31, 2017 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, May 9, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 14, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 14, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 22, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 7, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, January 31, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 31, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, January 31, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 31, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 31, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 15, 2016 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, August 15, 2016 | PRIORITY ACTION E-MAILED |
| Monday, August 15, 2016 | PRIORITY ACTION WRITTEN |
| Wednesday, July 20, 2016 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Thursday, July 14, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 14, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 14, 2016 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, January 20, 2016 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 20, 2016 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 20, 2016 | SUSPENSION LETTER WRITTEN |
| Tuesday, December 29, 2015 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Thursday, June 25, 2015 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, June 25, 2015 | LETTER OF SUSPENSION E-MAILED |
| Thursday, June 25, 2015 | SUSPENSION LETTER WRITTEN |
| Monday, June 8, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 8, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 1, 2015 | ASSIGNED TO LIE |
| Tuesday, May 26, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 26, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 26, 2014 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 26, 2014 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 25, 2014 | ASSIGNED TO EXAMINER |
| Thursday, August 21, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 15, 2014 | NEW APPLICATION ENTERED |